Research Introduction Member Research Publications Board Cancer Immunotherapy Ⅰ Cancer Immunotherapy Ⅰ Cancer Immunotherapy Ⅱ Cancer therapy Virus-Theragnosis
1 InnoAbs Lab has long years of experience to develop highly specific monoclonal antibodies (mAbs) with therapeutic potential using phage display technology and intensive in vitro/in vivo efficacy and toxicity evaluation studies. Specific research areas are on: 1 Research & development of therapeutic antibody candidates specifically targeting tumor-associated antigens or neoantigens in cancers 2 Research & development of immune checkpoint inhibitors targeting novel immune checkpoint proteins as well as PD-1/PD-L1
